Pfizer, BioNTech say bivalent booster performs better against BA.5 omicron subvariant
Pfizer and BioNTech said that updated data from a Phase 2-3 clinical trial shows the bivalent booster performed better a...
Pfizer and BioNTech said that updated data from a Phase 2-3 clinical trial shows the bivalent booster performed better a...
COVID vaccine boosters : Pfizer for ages 12 and up, Moderna for ages 18 and up. Now, younger kids can join in. The FDA t...